Related Experiment Video

Updated: Jun 13, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Hepatic artery resistance in children with obesity and fatty liver

Samil Hizli1, A Koçyigit, N Arslan

  • 1MH Ankara Keçiören Research and Training Hospital, Pediatric Gastroenterology, Hepatology and Nutrition Clinic Ankara, Dokuz Eylül University, Faculty of Medicine, Izmir, Turkey. shizli@yahoo.com

Indian Journal of Pediatrics
|April 28, 2010
PubMed

Insights

Hepatic artery resistive index (HARI) positively correlates with increased body mass index (BMI) and fatty liver severity in children with non-alcoholic fatty liver disease (NAFLD). HARI may indicate early hemodynamic changes in pediatric NAFLD.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Medical Imaging

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent in children.
  • Assessing hemodynamic changes in pediatric NAFLD is crucial for early intervention.
  • Body mass index (BMI) and hepatosteatosis grade are key indicators in pediatric NAFLD.

Purpose of the Study:

  • To investigate the correlation between hepatic artery resistive index (HARI) and BMI in children with NAFLD.
  • To assess the relationship between HARI and the degree of hepatosteatosis in pediatric NAFLD patients.
  • To explore HARI as a potential marker for early hemodynamic alterations in pediatric NAFLD.

Main Methods:

  • Study included 33 healthy, 33 overweight, and 66 obese adolescents.
  • Participants were categorized based on BMI and ultrasonography-confirmed fatty liver grade.
  • Hepatic artery resistive index (HARI) was measured and correlated with BMI and steatosis severity.

Main Results:

  • A significant positive correlation was found between HARI and BMI (r=0.533, p<0.0001).
  • HARI showed a strong positive correlation with the degree of fatty liver (r=0.630, p<0.0001).
  • These findings indicate a direct relationship between hemodynamic changes and disease severity in pediatric NAFLD.

Conclusions:

  • HARI is positively correlated with BMI and hepatosteatosis grade in obese children with NAFLD.
  • HARI may serve as an early indicator of hemodynamic changes in the hepatic tissue of children with fatty liver.
  • This suggests HARI's potential utility in monitoring pediatric NAFLD progression before severe stages develop.
Abstract

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):